"Test, don't guess and stress." It's a phrase we say often, and today's episode, we are putting the phrase to the test. Join us in taking a deep dive into the powerful testing capabilities of RGCC International and how they are reshaping personalized cancer care. From identifying circulating tumor cells to mapping out which therapies (both conventional and natural) may be most effective, their tests can provide actionable, individualized insight so that you and your BCC Coach can make a solid plan of action. Our guest, Dr. Terri Beim, has spent over a decade working directly with RGCC's tests and technologies and is dedicated to educating medical professionals on how to use these tools to support real patients in real time. Now, you get to hear directly from her on how their liquid biopsy tests and other innovative technologies can help guide you and your BCC Coach into turning your results into a clear, data-driven healing plan that can be monitored every step of the way. Because the more you know, the more effectively you can heal.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related